IQuity has been covered in the forums before, but this looks like new news. IQuity claims they can predict Multiple Sclerosis with 90% accuracy at least 8 months before traditional methods. They also claim their approach "can be applied to any disease".
IQuity Launches Healthcare Analytics...
Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis (2018) Saroufim et al
Abstract:
https://www.msard-journal.com/article/S2211-0348(18)30220-7/abstract
Summary article:
Hypertension More Common in MS Patients Than General Public, Study...
The European ME Alliance has been a member organisation of the European Federation of Neurological Associations since 2015 (https://www.efna.net/emea/)
This survey by EFNA includes M.E. https://www.surveymonkey.com/r/EFNA-YS
It's open until 21st May and findings will be published on World...
Study:
Five years before multiple sclerosis onset: Phenotyping the prodrome
http://journals.sagepub.com/doi/full/10.1177/1352458518783662
Press Release:
A constellation of symptoms presages first definitive signs of multiple sclerosis...
Study: http://n.neurology.org/content/early/2018/07/03/WNL.0000000000005906
Summary: https://www.nationalmssociety.org/About-the-Society/News/Study-Finds-Exposure-to-Organic-Solvents-Smoking
The genes that have been shown to affect MS susceptibility include HLA genes. Thought the HLA link...
Brain volume loss in Multiple Sclerosis patients with no evidence of disease activity predicts future disability. Brain atrophy has recently been recognized as a pivotal biomarker that is closely associated to disability in patients with MS...
A review of vitamins and dietary supplements by patients with Multiple Sclerosis found that the only "vitamin" with sufficient evidence to support supplementation was Vitamin D.
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review...
The following list of studies and other papers could be helpful with regard to the claim that symptoms classified as 'fatigue' can't be measured objectively, or that potential objective measures are too unspecific.
In the field of MS research, some people looked for objective measures...
Possibly relevant to ME given the potential involvement of both microglia in the brain and the microbiome in the illness.
The article, https://medicalxpress.com/news/2018-05-gut-neurologic-disease.amp
https://www.nature.com/articles/s41586-018-0119-x
Proof that the Guardian cares, as long as you have the acceptable (to them) illnesses.
https://www.theguardian.com/commentisfree/2018/may/10/disabled-people-internment-care
This is a few years old, but really highlights the similarities between these two illnesses (and thus makes the difference in treatments more stark).
Does anybody with any understanding of the specifics here have any comments? What do we think: is ME like MS? Certainly, the early literature...
http://www.bbc.co.uk/news/resources/idt-sh/caroline_wyatt_multiple_sclerosis
ME and Rituximab get a very brief mention each. An interesting account of HSCT ("Stem Cell Reboot").
From what I can see, there's a lot of conjecture here, more than anything else. It's looking at the role of hormones in autoimmune diseases, and whether testosterone is protective. There are a few links to small/emerging studies.
Info here...
ME Association Press Release: People with M.E. ‘measurably more disabled’ than people with Multiple Sclerosis | 16 March 2018
http://www.meassociation.org.uk/2018/03/me-association-press-release-people-with-m-e-measurably-more-disabled-than-people-with-multiple-sclerosis-16-march-2018/
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.